Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Trading Update

7 Oct 2021 07:00

RNS Number : 2746O
Thruvision Group PLC
07 October 2021
 

7 October 2021

 

Thruvision Group plc

 

("Thruvision" or the "Group")

 

Trading Update

 

 

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market, is pleased to provide an update on trading for the six months ended 30 September 2021.

 

Revenues for the period are expected to be £2.0 million (H1FY21 £4.7 million, H2FY21 £2.0 million). The reduction reflects the fact that last year's comparative included a material order (of £3.0 million) from US Customs and Border Protection (CBP) as described in the results announcement at the time. The period under review did not benefit from a similar order, although, as set out below, we are in ongoing discussions with CBP about potential orders for the second half.

 

Profit Protection

 

Profit Protection revenues grew strongly, by 67%, to £1.0 million (H1FY21 £0.6 million), driven by repeat orders from customers who first purchased from us in the last 12 months. As we explained in our recent Annual Report, we believe that Profit Protection is an important growth market where, in October alone, sales are to expected to exceed those of the entire the first half as our customers prepare for Christmas trading. We are particularly pleased with the high levels of interest in our offering in the strategically important US Profit Protection market where, as well as reducing staff theft, organisations are seeking to improve work place safety after a number of fatal gun-related incidents in distribution centres.

 

US Customs

 

Driven by significant immigration pressure on the southern border with Mexico, our activity levels with CBP are currently very high. Many hundreds of officers are now proficient in using our technology to check immigrants for contraband and weapons at more than 20 locations on the border. With this firm operational base established, we are in discussions about upgrading and expanding the Thruvision fleet more widely across CBP and expect further order flow in the second half as a result.

 

Aviation

 

In Aviation, which has of course been hugely impacted by Covid-19, we have continued to make progress towards US Transportation Security Administration (TSA) accreditation. Such accreditation would enable the use of Thruvision for passenger security screening in US airports. As passenger numbers recover and travel processes permanently adapt to Covid-19, we expect to see renewed interest in our technology given its inherent 'safe distance / no touch' capabilities.

 

International

 

We received no orders in the period from Asia or the Middle East, but have seen continued interest in our technology and we remain optimistic that our business in these regions will recover as more normal trading conditions return.

 

Outlook

 

We continue to manage costs carefully and effectively, with cash of £4.1 million on 30 September 2021 (31 March 2021: £7.3 million). A build-up in our stock levels to support our Profit Protection customers' busy period accounted for £0.9 million of the reduction since the start of the period, with this inventory now allowing us to deliver the strong October sales as described above.

 

Looking forward, we expect to maintain our strong growth rate in Profit Protection across the UK, US and Europe. We also expect to make material progress in expanding our remit with CBP and, in the medium term, win business with further Customs agencies globally. Subject to continued positive progress with TSA, we still see clear longer-term opportunities for our technology in the Aviation sector.

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Tom Blundell

 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford, and Washington DC.

 

 

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFDIFLRIIL
Date   Source Headline
28th Feb 20258:38 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
26th Feb 20253:16 pmRNS-RNew product launch
18th Feb 202512:45 pmGNWForm 8.3 - [THRUVISION GROUP PLC- 17 02 2025] - (CGAML)
18th Feb 20258:00 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
17th Feb 202511:21 amGNWForm 8.3 - [THRUVISION GROUP PLC- 14 02 2025] - (CGAML)
17th Feb 202511:14 amRNSForm 8.3 - Thruvision Group plc
17th Feb 20258:27 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
14th Feb 202512:02 pmRNSForm 8.3 - Thruvision Group plc
14th Feb 20259:09 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
13th Feb 20257:00 amRNSTrading update and Progress on Strategic Review
7th Feb 20252:08 pmRNSForm 8.3 - Thruvision Group PLC
7th Feb 202512:14 pmRNSHolding(s) in Company
7th Feb 202510:52 amRNSForm 8.3 - Thruvision Group plc
7th Feb 20258:17 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
6th Feb 20255:05 pmRNSForm 8.3 - Thruvision Group PLC
6th Feb 202512:08 pmRNSForm 8.3 - Thruvision Group PLC
6th Feb 202510:43 amRNSRule 8.3 - Thruvision Group PLC
4th Feb 202512:06 pmRNSForm 8.3 - Thruvision Group PLC
30th Jan 202510:58 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
29th Jan 202511:38 amRNSForm 8.3 - Thruvision Group plc
24th Jan 20256:00 pmRNSForm 8.3 - Thruvision Group plc
23rd Jan 20251:53 pmRNSForm 8.3 - Thruvision Group PLC
22nd Jan 20255:03 pmRNSForm 8.3 - Thruvision Group PLC
21st Jan 20251:56 pmRNSForm 8.3 - Thruvision Group PLC
20th Jan 202512:12 pmRNSForm 8.3 - Thruvision Group PLC
20th Jan 20257:00 amRNSForm 8.3 - Thruvision Group plc
17th Jan 202512:11 pmRNSForm 8.3 - Thruvision Group plc
16th Jan 202511:29 amRNSForm 8.3 - Thruvision Group plc
15th Jan 20255:38 pmRNSForm 8 (OPD) - Thruvision Group plc
15th Jan 20251:12 pmGNWForm 8.3 - [THRUVISION GROUP PLC - Opening Disclosure - 14 01 2025] - (CGAML)
15th Jan 202512:58 pmGNWInvesco Ltd: Form 8.3 -Thruvision Group PLC; Opening position disclosure
15th Jan 202512:09 pmRNSForm 8.3 - Thruvision Group PLC
15th Jan 202511:42 amRNSForm 8.3 - Thruvision Group plc
15th Jan 202511:05 amRNSForm 8.3 - Thruvision Group Plc
15th Jan 20258:53 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
14th Jan 20257:00 amRNSStrategic Review
30th Dec 20247:00 amRNSAppointment of Chief Executive Officer
13th Dec 202412:38 pmRNSSharesave option grant to Executive Director
20th Nov 202410:45 amRNSBlocklisting update
20th Nov 202410:41 amRNSBlocklisting update
18th Nov 202410:50 amRNSAward of Share Options to Executive Director
15th Nov 20245:00 pmRNSHolding(s) in Company
14th Nov 202412:34 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSIssue of Equity
24th Oct 20247:00 amRNSInterim Results
14th Oct 20247:00 amRNSHalf year trading update and Board changes
19th Sep 202411:50 amRNSResult of AGM
28th Jun 20247:00 amRNSFinal Results
12th Jun 20247:00 amRNSResults notification
3rd Jun 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.